Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Polycystic Kidney Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT06658964
What this trial is testing

Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects

Who this might be right for
ADPKD (autosomal Dominant Polycystic Kidney Disease)
Jemincare 48
Not applicableActive Not RecruitingNCT04907799
What this trial is testing

Daily Caloric Restriction in ADPKD

Who this might be right for
Autosomal Dominant Polycystic KidneyOverweight and Obesity
University of Colorado, Denver 125
Large-scale testing (Phase 3)Study completedNCT02127437
What this trial is testing

Lanreotide In Polycystic Kidney Disease Study

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease (ADPKD
Assistance Publique - Hôpitaux de Paris 159
Not applicableStudy completedNCT01039987
What this trial is testing

Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
University of Pittsburgh 211
Not applicableStudy completedNCT06867471
What this trial is testing

Effects of Exogenous Ketosis on Proteinuria and Renal Function

Who this might be right for
Renal Insufficiency, ChronicPolycystic Kidney DiseasesProteinuria+1 more
Gødstrup Hospital 45
Not applicableStudy completedNCT02250287
What this trial is testing

New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Autosomal Dominant Polycystic Kidney DiseaseKidney Disease
Mayo Clinic 20
Testing effectiveness (Phase 2)Study completedNCT03541447
What this trial is testing

Tolvaptan-Octreotide LAR Combination in ADPKD

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Mario Negri Institute for Pharmacological Research 20
Testing effectiveness (Phase 2)Looking for participantsNCT05478083
What this trial is testing

A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease

Who this might be right for
Polycystic Liver DiseaseAutosomal Dominant Polycystic Kidney
University Medical Center Groningen 36
Large-scale testing (Phase 3)Study completedNCT01022424
What this trial is testing

A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002]

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Otsuka Pharmaceutical Co., Ltd. 13
Early research (Phase 1)Study completedNCT04908462
What this trial is testing

To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AL01211 in Healthy Volunteers

Who this might be right for
Autosomal Dominant Polycystic Kidney
AceLink Therapeutics, Inc. 69
Early research (Phase 1)Not Yet RecruitingNCT07463053
What this trial is testing

Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volunteers

Who this might be right for
ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Jemincare 8
Large-scale testing (Phase 3)Study completedNCT00428948
What this trial is testing

Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Who this might be right for
Polycystic Kidney Disease, Autosomal Dominant
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,445
Not applicableUnknownNCT02729662
What this trial is testing

Efficacy of Tolvaptan on ADPKD Patients

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Kyorin University 118
Early research (Phase 1)Not Yet RecruitingNCT07565441
What this trial is testing

Drug-Drug Interactions of JMKX003142 in Healthy Participants

Who this might be right for
ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Jemincare 112
Not applicableEnded earlyNCT01589705
What this trial is testing

The Relation Between Uric Acid Level and Endothelial Dysfunction in Patients With Polycystic Kidney Disease

Who this might be right for
Polycystic Kidney, Autosomal Dominant
TC Erciyes University 150
Early research (Phase 1)Study completedNCT05521191
What this trial is testing

RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Autosomal Dominant Polycystic Kidney DiseaseADPKDPolycystic Kidney, Autosomal Dominant
Regulus Therapeutics Inc. 68
Large-scale testing (Phase 3)Ended earlyNCT04152837
What this trial is testing

Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Polycystic Kidney Disease, AdultADPKD
Palladio Biosciences 7
Early research (Phase 1)Study completedNCT03687554
What this trial is testing

Effect of Venglustat in Patients With Renal Impairment

Who this might be right for
Healthy VolunteersPolycystic Kidney, Autosomal Dominant
Genzyme, a Sanofi Company 24
Large-scale testing (Phase 3)Study completedNCT00309283
What this trial is testing

Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Mario Negri Institute for Pharmacological Research 78
Early research (Phase 1)Active Not RecruitingNCT06734234
What this trial is testing

Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Kidney Disease
GlaxoSmithKline 86
Next Page